Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Goy

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Cancer|December 6, 2005
The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphomaAndre Goy, John Stewart, Bedia A Barkoh, et al.
Expert Review of Molecular Diagnostics|November 18, 2010
Ovarian cancer biomarkers for molecular biosensors and translational medicineK Stephen Suh, Sang W Park, Angelica Castro, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphomaRyan D Cassaday, Andre Goy, Suresh Advani, et al.
Journal of Clinical Bioinformatics|April 3, 2015
Clinical decision support systems for improving diagnostic accuracy and achieving precision medicineChristian Castaneda, Kip Nalley, Ciaran Mannion, et al.
Journal of Oncology|January 16, 2013
Early detection biomarkers for ovarian cancerSreeja Sarojini, Ayala Tamir, Heejin Lim, et al.
Clinical Lymphoma & Myeloma|September 1, 2009
Mantle cell lymphoma: biological insights and treatment advancesJohn P Leonard, Michael E Williams, Andre Goy, et al.
Leukemia & Lymphoma|January 7, 2006
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphomaBarbara Pro, Luis Fayad, Peter McLaughlin, et al.
Cancers|February 26, 2025
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid MalignanciesScott D Rowley, Maher Albitar, Melissa F Baker, et al.
Cancer|December 19, 2007
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphomaYasuhiro Oki, Barbara Pro, Luis E Fayad, et al.
Journal of Oncology|July 3, 2013
Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicineK Stephen Suh, Sreeja Sarojini, Maher Youssif, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Cancer|December 6, 2005
The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphomaAndre Goy, John Stewart, Bedia A Barkoh, et al.
Expert Review of Molecular Diagnostics|November 18, 2010
Ovarian cancer biomarkers for molecular biosensors and translational medicineK Stephen Suh, Sang W Park, Angelica Castro, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphomaRyan D Cassaday, Andre Goy, Suresh Advani, et al.
Journal of Clinical Bioinformatics|April 3, 2015
Clinical decision support systems for improving diagnostic accuracy and achieving precision medicineChristian Castaneda, Kip Nalley, Ciaran Mannion, et al.
Journal of Oncology|January 16, 2013
Early detection biomarkers for ovarian cancerSreeja Sarojini, Ayala Tamir, Heejin Lim, et al.
Clinical Lymphoma & Myeloma|September 1, 2009
Mantle cell lymphoma: biological insights and treatment advancesJohn P Leonard, Michael E Williams, Andre Goy, et al.
Leukemia & Lymphoma|January 7, 2006
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphomaBarbara Pro, Luis Fayad, Peter McLaughlin, et al.
Cancers|February 26, 2025
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid MalignanciesScott D Rowley, Maher Albitar, Melissa F Baker, et al.
Cancer|December 19, 2007
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphomaYasuhiro Oki, Barbara Pro, Luis E Fayad, et al.
Journal of Oncology|July 3, 2013
Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicineK Stephen Suh, Sreeja Sarojini, Maher Youssif, et al.
Pageof 17